Bradley Mark J. Dexcom Inc Transaction History

Bradley Mark J.

$99.3 Million
Q2 2023

A detailed history of Bradley Mark J. transactions in Dexcom Inc stock. As of the latest transaction made, Bradley Mark J. holds 31,278 shares of DXCM stock, worth $2.5 Million. This represents 4.05% of its overall portfolio holdings.

Number of Shares

31,278

Previous 49,233 36.47%

Holding current value

$2.5 Million

Previous $5.72 Million 29.73%

% of portfolio

4.05%

Previous 4.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $2.02 Million - $2.35 Million	-17,955 Reduced 36.47%	31,278 $4.02 Million
Q1 2023 Jun 09, 2023	BUY	$104.0 - $122.92 $4,160 - $4,916	40 Added 0.08%	49,233 $5.72 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $599,352 - $708,387	5,763 Added 13.27%	49,193 $5.72 Million
Q4 2022 Feb 15, 2023	SELL	$84.98 - $122.67 $12,492 - $18,032	-147 Reduced 0.34%	43,430 $4.92 Million
Q3 2022 Nov 15, 2022	BUY	$76.35 - $94.18 $93,528 - $115,370	1,225 Added 2.89%	43,577 $3.51 Million
Q2 2022 Jul 15, 2022	BUY	$67.99 - $132.89 $2.15 Million - $4.2 Million	31,609 Added 294.23%	42,352 $3.16 Million
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $15,052 - $20,832	-160 Reduced 1.47%	10,743 $5.5 Million
Q4 2021 Mar 07, 2022	SELL	$129.87 - $162.82 $163,636 - $205,153	-1,260 Reduced 10.36%	10,903 $5.86 Million
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $67,227 - $90,203	-630 Reduced 4.92%	12,163 $6.65 Million
Q2 2021 Jul 22, 2021	SELL	$80.99 - $107.93 $74,915 - $99,835	-925 Reduced 6.74%	12,793 $5.46 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $25,013 - $30,898	-295 Reduced 2.11%	13,718 $4.93 Million
Q4 2020 Feb 18, 2021	BUY	$78.0 - $104.5 $1.09 Million - $1.46 Million	14,013 New	14,013 $5.18 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

News

Stay updated on Bradley Mark J. with notifications on news.

Account